CAS ID: | 321661-62-5 |
Molecular Formula: | C18H26O5 |
Molecular Weight: | 322.4 g/mol |
Monoisotopic Mass: | 322.178 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 25581517 | Target ID | T0540 |
Uniprot ID | Nuclear receptor subfamily 4 group A member 1 | Name | Nuclear receptor subfamily 4 group A member 1 |
Model | vitro,human,mice | Fibrosis Disease | Skin fibrosis |
Process I | |||
Process II | myofibroblasts differentiation | ||
Process III | prevenet collagen deposition | ||
Mechanism | Targeting Smad signaling |
Reference Record 2
PubMed ID | 25581517 | Target ID | T0540 |
Uniprot ID | Nuclear receptor subfamily 4 group A member 1 | Name | Nuclear receptor subfamily 4 group A member 1 |
Model | vitro,human,mice | Fibrosis Disease | Pulmonary fibrosis |
Process I | |||
Process II | myofibroblasts differentiation | ||
Process III | prevenet collagen deposition | ||
Mechanism | Targeting Smad signaling |
Reference Record 3
PubMed ID | 25581517 | Target ID | T0540 |
Uniprot ID | Nuclear receptor subfamily 4 group A member 1 | Name | Nuclear receptor subfamily 4 group A member 1 |
Model | vitro,human,mice | Fibrosis Disease | Renal fibrosis |
Process I | |||
Process II | myofibroblasts differentiation | ||
Process III | prevenet collagen deposition | ||
Mechanism | Targeting Smad signaling |
Reference Record 4
PubMed ID | 25581517 | Target ID | T0540 |
Uniprot ID | Nuclear receptor subfamily 4 group A member 1 | Name | Nuclear receptor subfamily 4 group A member 1 |
Model | vitro,human,mice | Fibrosis Disease | Liver fibrosis |
Process I | |||
Process II | myofibroblasts differentiation | ||
Process III | prevenet collagen deposition | ||
Mechanism | Targeting Smad signaling |
PubChem: | 10687292 |
ChEMBL: | CHEMBL1221517 |